Cita APA

Blake, Z., Marks, D. K., Gartrell, R. D., Hart, T., Horton, P., Cheng, S. K., . . . Saenger, Y. M. (2018). Complete intracranial response to talimogene laherparepvec (T-Vec), pembrolizumab and whole brain radiotherapy in a patient with melanoma brain metastases refractory to dual checkpoint-inhibition. J Immunother Cancer.

Citación estilo Chicago

Blake, Zoë, Douglas K. Marks, Robyn D. Gartrell, Thomas Hart, Patti Horton, Simon K. Cheng, Bret Taback, Basil A. Horst, y Yvonne M. Saenger. "Complete Intracranial Response to Talimogene Laherparepvec (T-Vec), Pembrolizumab and Whole Brain Radiotherapy in a Patient With Melanoma Brain Metastases Refractory to Dual Checkpoint-inhibition." J Immunother Cancer 2018.

Cita MLA

Blake, Zoë, et al. "Complete Intracranial Response to Talimogene Laherparepvec (T-Vec), Pembrolizumab and Whole Brain Radiotherapy in a Patient With Melanoma Brain Metastases Refractory to Dual Checkpoint-inhibition." J Immunother Cancer 2018.